The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma lacks immunogenicity: Follow-up characterization of PNAEμ-NLS

Oligonucleotides

Volumn 17, Issue 1, 2007, Pages 146-150

  Cutrona, Giovanna ^a   Boffa, Lidia C ^a   Mariani, Maria Rita ^a   Matis, Serena ^a,b   Damonte, Gianluca ^b   Millo, Enrico ^b   Roncella, Silvio ^c   Ferrarini, Manlio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c S Bartolomeo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE NUCLEIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; BURKITT LYMPHOMA; CANCER INHIBITION; CELL GROWTH; CHROMOSOME TRANSLOCATION; CROSS LINKING; EMULSION; ENHANCER REGION; EVALUATION; FEMALE; FOLLOW UP; GENE LOCUS; GENE OVEREXPRESSION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE C MYC; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; BURKITT LYMPHOMA; ENHANCER ELEMENTS (GENETICS); GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULINS; MICE; PEPTIDE NUCLEIC ACIDS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION, GENETIC;

MUS;

EID: 34247506712     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2007.9999     Document Type: Article

References (10)

1. BOFFA, L.C., CUTRONA, G., CILLI, M., MARIANI, M.R., MATIS, S., PASTORINO, M., DAMONTE, G., MILLO, E., RONCELLA, S., and FERRARINI, M. (2005). Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma. Oligonucleotides 15, 85-93.
2. BOFFA, L.C., CUTRONA, G., CILLI, M., MATIS, S., DAMONTE, G., MARIANI, M.R., MILLO, E., MORONI, M., RONCELLA, S., FEDELI, F., and FERRARINI, M. (2007a). Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc. Cancer Gene Ther. 14, 220-226.
3. BOFFA, L.C., MENICHINI, P., BOLOGNESI, C., CUTRONA, G., RONCELLA, S., DAMONTE, G., MILLO, E.,. MARIANI, M.R, MATIS, S., RUSSO, D., CILIUTTI, P., and M. FERRARINI. (2007b). Lack of mutagenicity and clastogenicity of a PNA targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 628, 129-137.
4. CUTRONA, G., CARPANETO, E. M., ULIVI, M., RONCELLA, S., LANDT, O., FERRARINI, M., and BOFFA, L.C. (2000). Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nature Biotech. 18, 300-303.
5. CUTRONA, G., CARPANETO, E.M., PONZANELLI, A., ULIVI, M., MILLO, E., SCARFÃ, S., RONCELLA, S., BENATTI, U., BOFFA, L.C., and FERRARINI, M. (2003). Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the Eμ enhancer. Cancer Res. 63, 6144-6148.
6. IOANNOU, X. P., GRIEBEL, P., HECKER, R.L., BABIUK, A., and VAN DRUNEN LITTEL-VAN DEN HURK S. (2002). The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76, 9002-9010.
7. KUPPERS, R., and DALLA FAVERA, R. (2001). Mechanisms of chromosomal translocations in B-cell lymphomas. Oncogene 20, 5580-5594.
8. MAO, S.J., YATES, M.T., OWEN, T.J., and KRISTENANSKY., J.L. (1989). Preparation of antibodies to a synthetic C terminus of hirudin and identification of an antigenic site. J. Immunol Methods 120, 45-50.
9. NIELSEN, P.E. (2001). Peptide nucleic acid targeting of double-stranded DNA. Methods Enzymol. 340, 329-340.
10. NIELSEN, P.E. (2002). PNA technology. Methods Mol. Biol. 208, 3-26.